Popel AS - Search Results

1

Development of a biomimetic peptide derived from collagen IV with anti-angiogenic activity in breast cancer.

Rosca EV, Koskimaki JE, Pandey NB, Wolff AC, Popel AS. Rosca EV, et al. Among authors: popel as. Cancer Biol Ther. 2011 Nov 1;12(9):808-17. doi: 10.4161/cbt.12.9.17677. Epub 2011 Nov 1. Cancer Biol Ther. 2011. PMID: 21878750 Free PMC article.

2

Identification of novel short peptides derived from the alpha 4, alpha 5, and alpha 6 fibrils of type IV collagen with anti-angiogenic properties.

Karagiannis ED, Popel AS. Karagiannis ED, et al. Among authors: popel as. Biochem Biophys Res Commun. 2007 Mar 9;354(2):434-9. doi: 10.1016/j.bbrc.2006.12.231. Epub 2007 Jan 16. Biochem Biophys Res Commun. 2007. PMID: 17239819 Free PMC article.

3

Anti-angiogenic peptides identified in thrombospondin type I domains.

Karagiannis ED, Popel AS. Karagiannis ED, et al. Among authors: popel as. Biochem Biophys Res Commun. 2007 Jul 20;359(1):63-9. doi: 10.1016/j.bbrc.2007.05.041. Epub 2007 May 14. Biochem Biophys Res Commun. 2007. PMID: 17531201 Free PMC article.

4

Peptides derived from type I thrombospondin repeat-containing proteins of the CCN family inhibit proliferation and migration of endothelial cells.

Karagiannis ED, Popel AS. Karagiannis ED, et al. Among authors: popel as. Int J Biochem Cell Biol. 2007;39(12):2314-23. doi: 10.1016/j.biocel.2007.06.018. Epub 2007 Jul 30. Int J Biochem Cell Biol. 2007. PMID: 17707681 Free PMC article.

5

Where is VEGF in the body? A meta-analysis of VEGF distribution in cancer.

Kut C, Mac Gabhann F, Popel AS. Kut C, et al. Among authors: popel as. Br J Cancer. 2007 Oct 8;97(7):978-85. doi: 10.1038/sj.bjc.6603923. Epub 2007 Oct 2. Br J Cancer. 2007. PMID: 17912242 Free PMC article.

6

Novel anti-angiogenic peptides derived from ELR-containing CXC chemokines.

Karagiannis ED, Popel AS. Karagiannis ED, et al. Among authors: popel as. J Cell Biochem. 2008 Jul 1;104(4):1356-63. doi: 10.1002/jcb.21712. J Cell Biochem. 2008. PMID: 18307172

7

A peptide derived from type 1 thrombospondin repeat-containing protein WISP-1 inhibits corneal and choroidal neovascularization.

Cano Mdel V, Karagiannis ED, Soliman M, Bakir B, Zhuang W, Popel AS, Gehlbach PL. Cano Mdel V, et al. Among authors: popel as. Invest Ophthalmol Vis Sci. 2009 Aug;50(8):3840-5. doi: 10.1167/iovs.08-2607. Epub 2009 Mar 11. Invest Ophthalmol Vis Sci. 2009. PMID: 19279315

8

A systems biology perspective on sVEGFR1: its biological function, pathogenic role and therapeutic use.

Wu FT, Stefanini MO, Mac Gabhann F, Kontos CD, Annex BH, Popel AS. Wu FT, et al. Among authors: popel as. J Cell Mol Med. 2010 Mar;14(3):528-52. doi: 10.1111/j.1582-4934.2009.00941.x. Epub 2009 Oct 16. J Cell Mol Med. 2010. PMID: 19840194 Free PMC article. Review.

9

Peptides derived from type IV collagen, CXC chemokines, and thrombospondin-1 domain-containing proteins inhibit neovascularization and suppress tumor growth in MDA-MB-231 breast cancer xenografts.

Koskimaki JE, Karagiannis ED, Rosca EV, Vesuna F, Winnard PT Jr, Raman V, Bhujwalla ZM, Popel AS. Koskimaki JE, et al. Among authors: popel as. Neoplasia. 2009 Dec;11(12):1285-91. doi: 10.1593/neo.09620. Neoplasia. 2009. PMID: 20019836 Free PMC article.

10

Pentastatin-1, a collagen IV derived 20-mer peptide, suppresses tumor growth in a small cell lung cancer xenograft model.

Koskimaki JE, Karagiannis ED, Tang BC, Hammers H, Watkins DN, Pili R, Popel AS. Koskimaki JE, et al. Among authors: popel as. BMC Cancer. 2010 Feb 1;10:29. doi: 10.1186/1471-2407-10-29. BMC Cancer. 2010. PMID: 20122172 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

342 results

Search Page

Filters